AdooQ BioScience is a supplier of biochemicals located in Irvine, CA since 2006. In the past five years, we have been a renowned name engaged in manufacturing and supplying small molecule inhibitors including kinase inhibitors on kinds of signal pathway, such as PI3K, AKT, HDAC, MARP etc.
Company WebsiteGSK1210151A is a novel selective inhibitor of the bromodomain and extra terminal (BET) family proteins BRD2, BRD3, and BRD4.
More Information Supplier PageGSK1210151A is a novel selective inhibitor of the bromodomain and extra terminal (BET) family proteins BRD2, BRD3, and BRD4.
More Information Supplier PageGSK 0660 is a selective PPAR?? antagonist (IC50 values are 0.155, > 10 and ??? 10 ??M at PPAR??, PPAR?? and PPAR?? respectively).
More Information Supplier PageGSK 0660 is a selective PPAR?? antagonist (IC50 values are 0.155, > 10 and ??? 10 ??M at PPAR??, PPAR?? and PPAR?? respectively).
More Information Supplier PageGSK 0660 is a selective PPAR?? antagonist (IC50 values are 0.155, > 10 and ??? 10 ??M at PPAR??, PPAR?? and PPAR?? respectively).
More Information Supplier PageGSK 0660 is a selective PPAR?? antagonist (IC50 values are 0.155, > 10 and ??? 10 ??M at PPAR??, PPAR?? and PPAR?? respectively).
More Information Supplier PageGSK 2334470 is a potent 3-phosphoinositide-dependent protein kinase (PDK1) inhibitor (IC50 ~ 10 nM).
More Information Supplier PageGSK 2334470 is a potent 3-phosphoinositide-dependent protein kinase (PDK1) inhibitor (IC50 ~ 10 nM).
More Information Supplier PageGSK 2334470 is a potent 3-phosphoinositide-dependent protein kinase (PDK1) inhibitor (IC50 ~ 10 nM).
More Information Supplier PageGSK 2334470 is a potent 3-phosphoinositide-dependent protein kinase (PDK1) inhibitor (IC50 ~ 10 nM).
More Information Supplier PageGSK 2334470 is a potent 3-phosphoinositide-dependent protein kinase (PDK1) inhibitor (IC50 ~ 10 nM).
More Information Supplier PageGSK 269962 is a potent Rho kinase (ROCK) inhibitor (IC50 values are 1.6 and 4 nM for recombinant human ROCK1 and ROCK2 respectively).
More Information Supplier PageGSK 269962 is a potent Rho kinase (ROCK) inhibitor (IC50 values are 1.6 and 4 nM for recombinant human ROCK1 and ROCK2 respectively).
More Information Supplier PageGSK 269962 is a potent Rho kinase (ROCK) inhibitor (IC50 values are 1.6 and 4 nM for recombinant human ROCK1 and ROCK2 respectively).
More Information Supplier PageGSK 269962 is a potent Rho kinase (ROCK) inhibitor (IC50 values are 1.6 and 4 nM for recombinant human ROCK1 and ROCK2 respectively).
More Information Supplier PageGSK-525762A is a small molecule inhibitor of the BET (Bromodomain and Extra-Terminal) family
More Information Supplier PageGSK-525762A is a small molecule inhibitor of the BET (Bromodomain and Extra-Terminal) family
More Information Supplier PageGSK-525762A is a small molecule inhibitor of the BET (Bromodomain and Extra-Terminal) family
More Information Supplier PageGSK-525762A is a small molecule inhibitor of the BET (Bromodomain and Extra-Terminal) family
More Information Supplier PageGSK-525762A is a small molecule inhibitor of the BET (Bromodomain and Extra-Terminal) family
More Information Supplier PageGSK 525768A is the enantiomer compound of GSK 525762A(HY-13032, which is a potent small molecule inhibitor that disrupt the function of the BET family of bromodomains (Brd2, Brd3, and Brd4); GSK 525768A has NO activity towards BET.
More Information Supplier PageGSK 525768A is the enantiomer compound of GSK 525762A(HY-13032, which is a potent small molecule inhibitor that disrupt the function of the BET family of bromodomains (Brd2, Brd3, and Brd4); GSK 525768A has NO activity towards BET.
More Information Supplier PageGSK 525768A is the enantiomer compound of GSK 525762A(HY-13032, which is a potent small molecule inhibitor that disrupt the function of the BET family of bromodomains (Brd2, Brd3, and Brd4); GSK 525768A has NO activity towards BET.
More Information Supplier PageGSK J1 is a potent and selective inhibitor of the H3K27 histone demethylases JMJD3 and UTX
More Information Supplier PageGSK J1 is a potent and selective inhibitor of the H3K27 histone demethylases JMJD3 and UTX
More Information Supplier PageGSK J1 is a potent and selective inhibitor of the H3K27 histone demethylases JMJD3 and UTX
More Information Supplier PageGSK J1 is a potent and selective inhibitor of the H3K27 histone demethylases JMJD3 and UTX
More Information Supplier PageGSK2193874 was identified as a selective, orally active TRPV4 blocker that inhibits Ca(2+) influx through recombinant TRPV4 channels and native endothelial TRPV4 currents.
More Information Supplier PageGSK2193874 was identified as a selective, orally active TRPV4 blocker that inhibits Ca(2+) influx through recombinant TRPV4 channels and native endothelial TRPV4 currents.
More Information Supplier PageGSK2193874 was identified as a selective, orally active TRPV4 blocker that inhibits Ca(2+) influx through recombinant TRPV4 channels and native endothelial TRPV4 currents.
More Information Supplier PageGSK-3787 is a potent and selective peroxisome proliferator-activated receptor ?? (PPAR??) antagonist (pIC50 = 6.6).
More Information Supplier PageGSK-3787 is a potent and selective peroxisome proliferator-activated receptor ?? (PPAR??) antagonist (pIC50 = 6.6).
More Information Supplier PageGSK-3787 is a potent and selective peroxisome proliferator-activated receptor ?? (PPAR??) antagonist (pIC50 = 6.6).
More Information Supplier PageGSK-3787 is a potent and selective peroxisome proliferator-activated receptor ?? (PPAR??) antagonist (pIC50 = 6.6).
More Information Supplier PageGSK-3787 is a potent and selective peroxisome proliferator-activated receptor ?? (PPAR??) antagonist (pIC50 = 6.6).
More Information Supplier PageGSK 650394 is a glucocorticoid- and serum-regulated kinase 1 (SGK1) inhibitor which displays antiproliferative properties against the LNCaP prostate carcinoma cell line.
More Information Supplier PageGSK 650394 is a glucocorticoid- and serum-regulated kinase 1 (SGK1) inhibitor which displays antiproliferative properties against the LNCaP prostate carcinoma cell line.
More Information Supplier PageGSK 650394 is a glucocorticoid- and serum-regulated kinase 1 (SGK1) inhibitor which displays antiproliferative properties against the LNCaP prostate carcinoma cell line.
More Information Supplier PageGSK 650394 is a glucocorticoid- and serum-regulated kinase 1 (SGK1) inhibitor which displays antiproliferative properties against the LNCaP prostate carcinoma cell line.
More Information Supplier PageGSK-923295, is a small-molecule inhibitor of the mitotic kinesin centromere-associated protein E, (CENP-E).
More Information Supplier PageGSK-923295, is a small-molecule inhibitor of the mitotic kinesin centromere-associated protein E, (CENP-E).
More Information Supplier PageGSK-923295, is a small-molecule inhibitor of the mitotic kinesin centromere-associated protein E, (CENP-E).
More Information Supplier PageGSK-923295, is a small-molecule inhibitor of the mitotic kinesin centromere-associated protein E, (CENP-E).
More Information Supplier PageGSK-923295, is a small-molecule inhibitor of the mitotic kinesin centromere-associated protein E, (CENP-E).
More Information Supplier PageGSK J4 is a cell permeable prodrug rapidly hydrolyzed by macrophage esterases to GSK-J1, a potent selective jumonji H3K27 demethylase inhibitor; attenuates lipopolysaccharide (LPS)-induced proinflammatory cytokine production in primary human macrophages (IC50 = 9 uM for the inhibition of TNF?? release).
More Information Supplier PageGSK J4 is a cell permeable prodrug rapidly hydrolyzed by macrophage esterases to GSK-J1, a potent selective jumonji H3K27 demethylase inhibitor; attenuates lipopolysaccharide (LPS)-induced proinflammatory cytokine production in primary human macrophages (IC50 = 9 uM for the inhibition of TNF?? release).
More Information Supplier PageGSK J4 is a cell permeable prodrug rapidly hydrolyzed by macrophage esterases to GSK-J1, a potent selective jumonji H3K27 demethylase inhibitor; attenuates lipopolysaccharide (LPS)-induced proinflammatory cytokine production in primary human macrophages (IC50 = 9 uM for the inhibition of TNF?? release).
More Information Supplier Page
